ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 81 filers reported holding ORCHARD THERAPEUTICS PLC in Q3 2021. The put-call ratio across all filers is 4.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $7,503 | -71.1% | 20,223 | -45.0% | 0.00% | – |
| Q1 2022 | $26,000 | -73.2% | 36,794 | -49.8% | 0.00% | – |
| Q4 2021 | $97,000 | +34.7% | 73,332 | +134.0% | 0.00% | – |
| Q3 2021 | $72,000 | -41.0% | 31,335 | +12.7% | 0.00% | – |
| Q2 2021 | $122,000 | -26.9% | 27,805 | +21.2% | 0.00% | – |
| Q1 2021 | $167,000 | -86.7% | 22,943 | -92.1% | 0.00% | – |
| Q4 2020 | $1,260,000 | +425.0% | 291,560 | +399.8% | 0.00% | – |
| Q3 2020 | $240,000 | -76.7% | 58,334 | -66.1% | 0.00% | – |
| Q2 2020 | $1,032,000 | +125.8% | 171,943 | +183.2% | 0.00% | – |
| Q1 2020 | $457,000 | +34.8% | 60,717 | +146.5% | 0.00% | – |
| Q4 2019 | $339,000 | +103.0% | 24,632 | +75.5% | 0.00% | – |
| Q3 2019 | $167,000 | – | 14,037 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 7,987,396 | $2,963,323 | 0.79% |
| TANG CAPITAL MANAGEMENT LLC | 2,000,000 | $742,000 | 0.11% |
| Artal Group S.A. | 1,803,858 | $669 | 0.04% |
| Forefront Analytics, LLC | 164,894 | $61,175 | 0.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,161,707 | $1,172,993 | 0.02% |
| Temasek Holdings (Private) Ltd | 4,319,049 | $1,602,367 | 0.01% |
| FEDERATED HERMES, INC. | 8,401,687 | $3,117,026 | 0.01% |
| Cormorant Asset Management, LP | 256,649 | $95 | 0.01% |
| Lane Generational LLC | 10,828 | $4,017 | 0.01% |
| Allegheny Financial Group LTD | 28,750 | $10,666 | 0.00% |